(Q40156163)

18 September 2017

title

Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines (English)

1 reference

18 September 2017

1 reference

10

Renata Stripecke

0 references

Antoni Ribas

3

object named as

Antoni Ribas

1 reference

18 September 2017

Richard C Koya

1

1 reference

18 September 2017

Takahiro Kimura

2

1 reference

18 September 2017

Nora Rozengurt

4

1 reference

18 September 2017

Gregory W Lawson

5

1 reference

18 September 2017

Emmanuelle Faure-Kumar

6

1 reference

18 September 2017

He-jing Wang

7

1 reference

18 September 2017

Harvey Herschman

8

1 reference

18 September 2017

Noriyuki Kasahara

9

1 reference

18 September 2017

Renata Stripecke

10

1 reference

18 September 2017

publication date

20 March 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

15

1 reference

18 September 2017

issue

5

1 reference

18 September 2017

page(s)

971-980

1 reference

Dendritic cells and the control of immunity

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Current developments of immunotherapy in the clinic

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Identification of proliferating dendritic cell precursors in mouse blood

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Current developments in cancer vaccines and cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300126

7 January 2021

Identifiers

DOI

10.1038/MT.SJ.6300126

1 reference

18 September 2017

1 reference